Incidence of kidney stones with topiramate treatment in pediatric patients

Epilepsia

Volumn 52, Issue 10, 2011, Pages 1890-1893

  Mahmoud, Adel A H ^a   Rizk, Tamer ^a   El Bakri, Nahid K ^b   Riaz, Muhammad ^b   Dannawi, Samer ^a   Al Tannir, Mohamad ^b  

^a Neurosciences Center   (Saudi Arabia)

^b KING FAHAD MEDICAL CITY   (Saudi Arabia)

Author keywords

Kidney; Stones; Topiramate; Ultrasound

Indexed keywords

TOPIRAMATE;

ARTICLE; CHILD; CLINICAL FEATURE; COMORBIDITY; FAMILY HISTORY; FEMALE; FOLLOW UP; HUMAN; KIDNEY DISEASE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORBIDITY; NEPHROLITHIASIS; PRIORITY JOURNAL; SCHOOL CHILD; TREATMENT DURATION;

AGE FACTORS; ANTICONVULSANTS; CHILD; EPILEPSY; FEMALE; FRUCTOSE; HUMANS; INCIDENCE; KAPLAN-MEIER ESTIMATE; KIDNEY CALCULI; MALE; RETROSPECTIVE STUDIES; SEX FACTORS;

EID: 80053568546     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2011.03245.x     Document Type: Article

References (20)

1. Bourgeois BFD,. (1999) Pharmacokinetics and metabolism of topiramate. Drugs Today 35: 43.
2. Brian RM, Ojas DS, Dean GA,. (2003) Drug-induced urinary calculi. Rev Urol 5: 227-231.
3. Coppola G, Caliendo G, Veggiotti P, Romeo A, Tortorella G, De Marco P,. (2002) Topiramate as add-on drug in children, adolescents and young adults with Lennox-Gastaut syndrome: an Italian multicentric study. Epilepsy Res 51: 147-153. (Pubitemid 35283885)
4. Daniel MK, Kristina LP, Stephen YN,. (2011) Patients with and without prior urolithiasis have hypocitraturia and incident kidney stones while on topiramate. Urology 77: 295-298.
5. Deyoe LA, Cronan JJ, Breslaw BH,. (1995) New techniques of ultrasound and color Doppler in the prospective evaluation of acute renal obstruction. Do they replace the intravenous urogram? Abdom Imaging 20: 58-63.
6. Doose DR, Walker SA, Gisclon LG, Nayak RK,. (1996) Single-dose pharmacokinetics and effect of food on the bioavailability of topiramate, a novel antiepileptic drug. J Clin Pharmacol 36: 884-891. (Pubitemid 26384477)
7. Fowler KA, Locken JA, Duchesne JH, Williamson MR,. (2002) US for detecting renal calculi with non enhanced CT as a reference standard. Radiology 222: 109-113. (Pubitemid 34031474)
8. Hong KT, Ryu HW, Doo K, Cho JS, Cho A, Lim BC, Chae JH, Kim KJ, Hwang YS, Hwang H,. (2010) A case of pediatric nephrolithiasis associated with topiramate treatment. J Korean Child Neurol Soc 18: 112-116.
9. Johnson BA,. (2004) Progress in the development of topiramate for treating alcohol dependence: from a hypothesis to a proof-of concept study. Alcohol Clin Exp Res 28: 1137-1144. (Pubitemid 39108611)
10. Maalouf NM, Langston JP, Ness PCV, Moe OW, Sakhaee K,. (2011) Nephrolithiasis in topiramate users. Urol Res 39: 303-307.
11. Maryanoff BE, Costanzo MJ, Nortey SO, Greco MN, Shank RP, Schupsky JJ, Ortegon MP, Vaught JL,. (1998) Structure-activity studies on anticonvulsant sugar sulfamates related to topiramate enhanced potency with cyclic sulfate derivatives. J Med Chem 41: 1315-1343. (Pubitemid 28208186)
12. Middleton WD, Dodds WJ, Lawson TL,. (1988) Renal calculi: sensitivity for detection with US. Radiology 167: 239.
13. Passerotti C, Chow JS, Silva A,. (2009) Ultrasound versus computerized tomography for evaluating urolithiasis. J Urol 182: 1829-1834.
14. Philippi H, Boor R, Reitter B,. (2002) Topiramate and metabolic acidosis in infants and toddlers. Epilepsia 43: 744-747. (Pubitemid 34774257)
15. Richmond J,. (2007) The CARI guidelines. Radiological diagnosis of kidney stones. Nephrology 12: S34-S36.
16. Rosenfeld WE,. (1997) Topiramate: a review of preclinical, pharmacokinetic, and clinical data. Clin Ther 19: 1294-1308. (Pubitemid 28133269)
17. Sinclair D, Wilson S, Toi A,. (1989) The evaluation of suspected renal colic: ultrasound scan versus excretory urography. Ann Emerg Med 18: 556-559. (Pubitemid 19127697)
18. US Census Bureau, International Data Base. (2004), accessed on 30/01/2011.
19. Vega D, Maalouf NM, Sakhaee K,. (2007) Increased propensity for calcium phosphate kidney stones with topiramate use. Expert Opin Drug Saf 6: 547-557. (Pubitemid 351308213)
20. Welch BJ, Graybeal D, Moe OW, Maalouf NM, Sakhaee K,. (2006) Biochemical and stone-risk profiles with topiramate treatment. Am J Kidney Dis 48: 555-563. (Pubitemid 44402839)